Aktivitetsmätare, blood pressure monitor, blood glucose meter – everything possible is available today in the body-worn form.With the Bactrack Sky, it also applies a per mille.With various wearable gadgets, you can keep track of everything from how much you move to how high the blood sugar is and how fast the heart beats.Soon can you get when how much alcohol you have in the body.the Bactrack came to CES with its new bracelet of the Cloud, which has a sensor for measuring a per mille without having to breathe in a tube.the Sky does not give results in the form of a blodalkoholvärde as a regular instrument, but how much alcohol escapes the body through the skin transdermalalkoholvärde .
Pulse is one of JBL's more odd bluetoothhögtalare: A parallel history, like many others, but covered in leds that can change color in time with the music.CES day two: the Refrigerator with the huge screens and smart blood glucose meterWhen the company introduced new products ahead of CES on Wednesday was the Pulse 3 in the centre, a up to date model which is greatly improved on several levels.The great news is that Pulse 3 is waterproof with IPX7-classification, and can, therefore, follow with in the pool or tub.Leds are now being covered by a smooth transparent plastic shell instead of a grid as in the past, which makes the colors become much clearer and it looks like something an overwintered hippie could appreciate.another interesting news is Soundgear, a speaker you wear around your neck.
Wearables like the Apple Watch lack the components necessary to record more than basics.Chances are you haven t heard of PKvitality, a self-described biowearable affiliate of consumer electronics firm PKparis.But the firm s been plugging away for more than 20 years in the biological research business, developing innovative medical technologies for the consumer market.It s newest invention, the patented SkinTaste biosensor, is perhaps its wildest yet: An array of tiny needles that collect and analyze skin fluid.PKvitality describes interstitial fluid, which makes up as much as 16 percent of an average person s body weight and provides cells with nutrients, as a wealth of telling biomarkers.The company contends that the fluid s location near the top-most portion of the skin — roughly 1mm above pain nerves and blood vessels — makes it ideal for comfortable extraction.
Maybe your ungrateful family doesn t value all the thought and care you put into wrapping gifts, but that Scotch tape you re using is the true underappreciated workhorse: It s ubiquitous, immensely useful, and largely unrecognized as the modern chemical engineering marvel it is.The magic all started with Richard Drew, a scrappy banjo-playing researcher at 3M.In 1929 he was struggling to create a clear tape for meat-packers and candymakers—the cellophane kept ripping and warping near heat, and the adhesive wouldn t stick evenly.His work eventually led to today s Scotch Magic tape, and 3M has kept a tight seal on the recipe for its sandwich of polymers and carefully engineered chemicals ever since.It starts as cellulose, a long, tough, glucose-laced polymer that gives plants their structure.Typically it s extracted from cotton or wood and treated with acetic acid, the chemical that makes vinegar vinegary.
Wearables and trackers like the Fitbit have been around for years, and while the information they provide — heart rate, sleep patterns, GPS — is invaluable, it only scratches the surface of what biometric data can offer.Biometrics — the science and technology of analyzing biological data — can be as simple as taking your heart rate before and after a run, and as complicated as a blood test that determines your hormone and glucose levels.Companies like Adidas, Catapult, and Whoop have already developed advanced systems that track not just an athlete s movements and heart rate, but their precise velocity, changes of direction, acceleration, deceleration, jump height, and more.Major League Soccer clubs like Toronto FC, baseball teams like the Chicago Cubs and the Pittsburgh Pirates, and NBA teams the league over are just a few of the organizations that are making use of advanced data to get the most out of their athletes.Sometimes these biometric trackers are worn like a Fitbit, but more and more often they re smaller and less obtrusive, like the OptimEye — a futuristic device that uses multiple satellites to track athlete movements with incredible precision that s worn inside jerseys between the shoulder blades.In addition to being able to better track the movements and performance of players in action, solid biometric data can help athletes prevent injuries.
Fitbit cofounder and CEO James Park talked about his company s plans to delve into healthcare at a San Francisco event hosted by Quartz yesterday.This followed an earlier announcement that Fitbit has entered into a partnership agreement with Medtronic, the California-based medical technology company specializing in diabetes.While the public s attention is currently focused on Fitbit s acquisition of Pebble assets, Park wants to look toward future developments, which are centered on medicine.Wearing a Fitbit should be able to save your life, he said, insisting that a wearable device is trendy now, but could become a medical aid in the future.Drawing a clear correlation between daily activity, exercise, and glucose level is the next step, according to Park.Fitbit had an extremely successful initial public offering IPO in June last year, but its shares have dropped from $47.60 last July to a wobbling $8.Of course, the acquisition of Pebble s software and intellectual property IP could boost its product line and help its shares recover.And fostering deals with healthcare leaders like Medtronic could broaden the company s market scope beyond fitness fanatics, reducing its dependency on consumers by banking on strategic partnerships.In terms of production, the company has started to use robots for the assembly of microscopic parts.
Soon, your Fitbit won t just be monitoring how many steps you take in a day — it will also keep tabs on your glucose levels.On Tuesday, Medtronic and Fitbit announced a new partnership that seeks to integrate health and activity tracking for patients living with diabetes and their physicians and care teams.For the first time, Fitbit users will be able to take advantage of Medtronic s medical technology and gain valuable insights into how their exercise regimens impact glucose levels, hopefully leading to better management of the condition.And of course, it s manifesting itself as an app — myLog.We believe monitoring glucose is a critical element in the management of diabetes and therefore, glucose should be included among other vital signs.As such, it has never been more important to increase the collaboration between healthcare and technology to simplify daily diabetes management for the 29 million patients living with type 2 diabetes in the United States, said Laura Stoltenberg, vice president and general manager of Non-Intensive Diabetes Therapies at Medtronic.
MoreFitbit Blaze watches are displayed during the 2016 CES trade show in Las Vegas, Nevada January 6, 2016. Reuters - Wearable device maker Fitbit Inc said it had bought smartwatch maker Pebble's software and intellectual property as it looks to strengthen its position in the wearables market.Pebble, which began as a crowdfunded project in 2012 and raised more than $10 million in a Kickstarter campaign, was one of the first companies to make smartwatches that used electronic ink displays and connected to smartphones.The financial terms of the deal were not disclosed, although Bloomberg had earlier reported that it was valued at less than $40 million.Pebble will no longer produce or sell any of its smartwatches, according to the company's website.The overall wearables market grew 3.1 percent in the third quarter, with Fitbit's share accounting for 23 percent of the overall market, according to research firm IDC.
Aspartame — the artificial sweetener found in drinks like Diet Coke — is not good for you.If you believe otherwise, I admire your commitment to self-delusion.A new study published by a team of investigators at Massachusetts General Hospital found a possible reason aspartame doesn t help you lose weight — oh sorry, haven t you heard?Like most things in society, diet soda is probably a giant scam.Richard Hodin, a surgeon at Massachusetts General Hospital and the study s senior author, explained, Sugar substitutes like aspartame are designed to promote weight loss and decrease the incidence of metabolic syndrome, but a number of clinical and epidemiologic studies have suggested that these products don t work very well and may actually make things worse.Dr. Hodin and his team found that the artificial sweetener inhibits intestinal alkaline phosphatase IAP , which is a gut enzyme that researchers believe prevents obesity.
Aspartame—the artificial sweetener found in drinks like Diet Coke—is probably not good for you.If you believe otherwise, I admire your commitment to self-delusion.A new study published by a team of investigators at Massachusetts General Hospital found a possible reason aspartame doesn t help you lose weight—oh sorry, haven t you heard?Like most things in society, diet soda is probably a giant scam.Richard Hodin, a surgeon at Massachusetts General Hospital and the study s senior author, explained, Sugar substitutes like aspartame are designed to promote weight loss and decrease the incidence of metabolic syndrome, but a number of clinical and epidemiologic studies have suggested that these products don t work very well and may actually make things worse.Dr. Hodin and his team found that the artificial sweetener intestinal alkaline phosphatase IAP , which is a gut enzyme that researchers believe prevents obesity.
Google is developing two types of 'smart' contact lensTo continue providing news and award winning journalism, we rely on advertising revenue.To continue reading, please turn off your ad blocker or whitelist us.Google has been forced to put a pin in its plans for a 'smart' contact lens after plans for human testing ran into delays.Google is currently known to be developing two new types of contact lens.One of these is designed to monitor the blood glucose levels of diabetes patients, while the other is being created for people for far-sightedness that will offer auto-focusing.
Reuters – Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is progressing steadily.It is too early to say when exactly human clinical trials for these lenses will begin, a spokeswoman for the Basel-based drugmaker said in an email on Friday.This is a very technically complex process and both sides are learning as we go along.We will provide updates at the appropriate time, she said.Novartis Chief Executive Joe Jimenez said last year his company s Alcon eye care unit was on track to begin testing in 2016.In 2014, Jimenez said he hoped the lens would be on the market in about five years.Novartis and Google joined forces two years ago to develop two kinds of smart contact lenses: An autofocusing lens for people with presbyopia, or far-sightedness, and another for measuring blood glucose levels in diabetes patients.The lenses are now being developed with Alphabet Inc. s life sciences unit Verily, which was carved out from Google in 2015.Measuring blood sugar via the eye could allow diabetics to stop having to prick their fingers, while an autofocus contact lens would help people whose ability to focus is impaired when their eyes age.It is unclear when testing for the diabetes lens will start.Since the partnership with Google was launched in 2014, Alcon s sales have slid and its leadership team has been replaced.New division head Mike Ball has been tasked with halting the revenue decline in advance of a possible sale of the unit.But Novartis said that did not bar investment in innovative projects such as the lens effort with Google.Advancing innovation such as the smart lens technology, is a key part of Alcon s growth strategy, the spokeswoman said.The smart lens technology has the potential to transform eye care and further enhance our pipeline … in the contact lens and intraocular lens space.
An implant is placed under the skin and measures the presence of fat in the so-called interstitial fluid.on Top of the skin attached to a transmitter, which vibrates at high or low glucose levels.the Transmitter is connected to an app, where the measurement results are displayed.Three patients with diabetes in Sweden is testing a new type of glucose meter, where a sensor can sit under the skin in three months.Traditionally, it has been by sticking themselves in the finger and read off the level with the help of a strip.Now there are several types of blood glucose meter that continuously measures glucose levels through a sensor that is put outside of the body or as a small implants.
A foldable, recyclable bike helmet has been announced as the international winner of the 2016 James Dyson Award, an annual globe-spanning design competition which rewards innovative solutions to real-world problems.In claiming the prize, she beats several impressive runners-up — including a smart wearable asthma management system and glucose-monitoring contact lenses.I imagined this as a bike helmet specifically for bike sharing programs, Schiffer told Digital Trends.If it s raining in the morning and then nice in the afternoon, and you decide to cycle home as a result, you may not have a helmet with you — and it s not advisable to ride without one.My original idea was to make a helmet that could fold up really small.More: Researchers say this inflatable bike helmet is six times more effective than yours
Millions of people around the world suffer from diabetes, but until the 1920s there was no treatment for it.Sir Frederick Banting,who pioneered the use of insulin in treating the disease, was a Canadian scientist whose work earned him the Nobel prize.He only lived to be 49 but on November 14 - what would have been his 125th birthday - Google has celebrated him with a commemorative Doodle.The vital hormone that allows glucose to enter cells is called insulin and it is normally produced naturally in the pancreas.He served in the First World War despite initially being refused while in medical school for poor eyesight since the army wanted more doctors on the front line.Scientists including Edward Schafer had speculated that diabetes was caused by a lack of a protein hormone produced in the pancreas, which Schafer had named insulin.
Google recently published the full text of a patent for a contact lens that can monitor blood glucose and dispense insulin automatically, while Samsung patented a contact lens with an integrated camera just a few short weeks ago.The next great wave of tech innovation may come in the form of the one of the most intimate of all wearables: contact lenses.But the golden age of research in contact-lens technology has officially begun.As CEO of some of the world s largest online optical companies, I can say that contact lenses are poised to get a dramatic overhaul.Here s a look at innovations, both in the near term and further down the road, that are leading us toward the fabled smart contact.Since mass-produced contacts first emerged in the 1970s, advancements have come mainly in the form of thinner, softer, and cheaper lens materials, most notably silicone hydrogel, which allows more oxygen to reach the cornea.Contacts are now more comfortable than ever and even come in colors , but their actual functionality hasn t changed.In many respects, traditional manufacturers have been content to play it safe, sticking with a high-margin business even as Lasik and other new technologies have eaten into their share of the market.Still, contacts account for a more than $10-billion-a-year business, with more than 100 million wearers around the globe.That rate of progress is about to take a major tick upward, however, thanks to advances in materials science.They are backed by very real science, using the wonder-material graphene to detect light well into the infrared spectrum and fit a traditionally large detector into a tiny contact lens.
DarioHealth There was a lot of uncertainty when Apple announced that it was dropping the headphone jack for the iPhone 7.But DarioHealth, an Israeli-based healthcare company that is focusing on improving the lives of diabetics, had to rethinkDarioHealth is a software company that built a glucose-measuring device called Dario, which works with a mobile app.
Remember those old school chemistry sets that came in a cardboard box with a bunch of vials, plastic beakers, safety glasses and a booklet full of instructions for different experiments?London startup MEL Science is putting a high-tech twist on those, with virtual reality and augmented reality content that takes kids on a virtual tour inside a chemical reaction, right after they conduct an experiment in the real world.Subscribers to MEL Science get two new chemistry sets by snail mail each month for $49 each.The MEL Science app shows a 3-D model of glucose.The app was designed to enhance kids understanding of what s happening in a given experiment, with 3D graphics, macro photos and videos of molecules up-close.According to MEL Science CEO and founder Vassili Philippov, he decided to start the company after conducting science experiments to entertain and educate his own kids at home.
Attackers exploit flaws in the Animas OneTouch Ping insulin pump system to deliver dangerous insulin dosesThe Animas OneTouch Ping Glucose Management System has security vulnerabilities.Medical device manufacturer Animas, a subsidiary of Johnson & Johnson, is warning diabetic patients who use its OneTouch Ping insulin pumps about security issues that could allow hackers to deliver unauthorized doses of insulin.The vulnerabilities were discovered by Jay Radcliffe, a security researcher at Rapid7 who is a Type I diabetic and user of the pump.The flaws primarily stem from a lack of encryption in the communication between the device's two parts: the insulin pump itself and the meter-remote that monitors blood sugar levels and remotely tells the pump how much insulin to administer.The pump and the meter use a proprietary wireless management protocol through radio frequency communications that are not encrypted.
The US Food and Drug Administration has approved Medtronic s MiniMed 670G, a medical device that monitors a diabetic s sugar levels, and then automatically injects the required dose of insulin.This first-of-its kind automated insulin delivery system was approved for people over the age of 14 who have type 1 diabetes, and it s poised to make life considerably easier for the millions of people who suffer from this condition.People with type 1 diabetes can t produce enough insulin, a hormone that regulates the amount of glucose, or sugar, in our blood.So they must replenish their insulin stock either with multiple daily injections, or by pumping insulin through a tiny catheter.Unlike these manual techniques, Medtronic s MiniMed 670G is a hybrid closed system, meaning it autonomously tracks glucose levels about every five minutes or so, and then adjusts insulin levels with little or no input from the user.MiniMed 670G can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin, the FDA s Jeffrey Shuren said in a release.
There is momentous news for Type 1 diabetics.On Wednesday, the U.S. Food and Drug Administration FDA approved the first Hybrid Closed Loop insulin delivery system in the world, according to Medtronic and the Juvenile Diabetes Research Foundation JDRF .The Medtronic MiniMed 670G system is a wearable device that combines continuous blood-glucose monitoring — blood-sugar testing — with an insulin pump.The algorithm used to adjust insulin dosing, called SmartGuard HCL, was the last step in Medtronic s phased development of the closed-loop system.According to Richard M. Bergenstal, M.D., principal investigator of the study and executive director of the Park Nicollet International Diabetes Center in Minneapolis, The data from the pivotal trial were compelling and I am confident that this therapy will be well-received by both the clinical and patient community.This significant milestone represents an important step forward in the management of Type 1 diabetes and will improve the quality of life for those living with this chronic disease, said Derek Rapp, JDRF president and CEO.
Nick Dolding via Getty ImagesHow s this for a reality check: Ten years ago, MySpace was the top social media site, people turned to Pandora for music and Motorola was the top-selling cellphone.Mobile devices, wearable gadgets, and Internet-based technologies will help older adults age in place while monitoring their health and safety.Automotive technology is working toward making us all safer drivers, but for seniors, there s an even keener interest: It could easily help keep them safe on the road longer.Patients can already check their glucose levels and download the results to their doctors.Watch for the expansion of point-of-care monitoring devices, such as weight scales, heart and blood pressure monitors that send your readings directly to the doctor.
Whether you wanted to be less stressed, cut out junk food, or stop smoking, you probably defined some simple rules and rewards to influence your behaviour and hopefully achieve that goal.Nonetheless, gamification is destined for a bright future in many areas.Thanks to the emergence of 3D video and virtual reality applications that engage participants and to the ubiquity of smartphones and tablets, it is possible to get large numbers of people to play these games.So, physicians and other healthcare providers are beginning to ask how they can use gamification tools to help their patients engage in a healthy lifestyle, take their medications as directed, and even to feel less pain thanks to the distraction that a great game can create.In turn, pharmaceutical companies see gamification as a way to make patient education more effective and more measurable and to increase the patient s greater respect of their course of treatment.At a recent international medical conference in Paris, organised with the support of Ferring Pharmaceuticals, participating physicians met with gamification experts from Europe, the United States, and Israel.
The pancreas is responsible for making and releasing insulin, an enzyme that helps control the level of glucose in the blood -- the substance all cells in your body use as their main source of energy.Without regular manual injections of insulin up to six times a day, diabetics' insulin levels will drop to dangerously low levels, with potentially fatal consequences.Until now, type I diabetics have typically managed their condition by manually monitoring their blood glucose levels with simple probes, and then injecting themselves with insulin several times a day.More recently, glucose pumps have been helping to automate the process: the pumps deliver insulin when needed through a tiny tube, known as a cannula, under the skin.From as early as next year, medical hardware companies are expected to release devices known as "artificial pancreases": closed-loop systems that will automatically monitor the wearer's glucose level and top it up as and when needed -- courtesy of an algorithm stored on a simple Android phone.That's really difficult to achieve in people with type I diabetes," Dr Roman Havorka, who leads the Cambridge University research, told ZDNet.
To nobody s surprise, Apple has merged audio into the Lightning connector on the iPhone 7, removing the 3.5mm audio jack.As evidence of the lack of surprise, DarioHealth unveiled a new glucose meter on Thursday, one day after Apple s announcement, which works with the iPhone s Lightning connector.Previously, the DarioHealth blood glucose monitoring system connected via the audio jack.The new device offers the same functionality and design, the only difference is the connector.See Also: How close are we to the robotic human heart?This news comes as no surprise to us, and we ve been working on a solution for quite some time now, said DarioHealth CEO, Erez Raphael.
Long-term exposure to air pollution in the area where you live increases your risk of developing Type 2 diabetes, according to new research.Scientists at the German Centre for Diabetes Research, have been studying the effect of pollution particles on insulin resistance in humans.They found that exposure to air pollution near your home increases the risk of developing insulin resistance as a pre-diabetic state of type 2 diabetes.Whether the disease becomes manifest and when this occurs is not only due to lifestyle or genetic factors, but also due to traffic-related air pollution, said researcher Professor Annette Peters.Owen Richards via Getty ImagesThe study, which used data from 3,000 patients, concluded that people who already have an impaired glucose metabolism pre-diabetic individuals are particularly vulnerable to the effects of pollution.
If your baking recipe requires some ripe bananas and all you have is some near-green ones, a few egg yolks can save the day.Whether you like making banana bread, pancakes, or muffins, Stella Sparks at Serious Eats has a trick you should keep up your sleeve: raw egg yolks quickly ripen bananas.The amylase enzyme found in egg yolks turns the starch in unripened bananas into a combination of maltose and glucose, or liquid sugar.This makes the banana ripen in about 30 minutes so it softens up and gets much sweeter.So the next time you need to ripen some bananas fast, mash them together with the number of eggs the recipe calls for and wait at least half an hour.This trick doesn t help you if you re just looking to snack on a banana or make a smoothie, but there are other methods you can try for those situations.
Remembering to apply your eye drops every day is a pain.Even when they re being used to treat serious conditions like glaucoma, which can cause blindness, there is still plenty of evidence that people will default on their medication over time.Now, there s an effort to create a contact lens capable of delivering doses of medication to the eye over a prolonged period of time.There are data to prove that 50 percent of patients given eye drops for glaucoma will stop taking them, Dr. Joseph Ciolino, an ophthalmologist at Massachusetts Eye and Ear and an assistant professor at Harvard Medical School, told Digital Trends.We re trying to unburden them of that obligation.It s one more thing people don t have to remember, a hassle they don t necessarily have to deal with.
When it comes to keeping track of diabetes, the manual process can be a bit of a pain.Healthtech startup Health2Sync, which launched at the Hardware Battlefield at CES 2014, wants to change all that with a cheap accessory that connects to most standard glucose meters and syncs your blood glucose levels straight to your phone.The company announced today it has secured a $3 million Series A round led by WI Harper Group, with participation in the round by Cherubic Ventures, iSeed Ventures and SparkLabs Global Ventures.According to the company s press release, Health2Sync will use the funding to continue product development and accelerate growth overseas in markets like Japan, China and Southeast Asia.At its core, the Health2Sync is a cable that connects your smartphone to your glucose meter via the headphone jack to get the two devices talking.Once these devices are connected, data stored on your glucose meter will sync with your smartphone via the Health2Sync app.
Rumors are swirling about the next iPhone event, which is likely to be held on September 7, and it s reportedly going to see the introduction of the Apple Watch 2.It s changed my life in meaningful ways, including losing a lot of weight, encouraging an active lifestyle and just making me more aware of myself.I feel like a total idiot going for a run with my wrist computer, but having to carry my iPhone as well to track it properly with Runkeeper or Strava.I d love to see more options at the lower end to go along with the Sport strap, and a wider range of Nylon straps – I m pining for something like the James Bond strap I ve had on other watches.Anyone with an Apple Watch will tell you that god-awful charger that comes in the box will burn you multiple times over; be it by not charging because it s not perfectly on the base or you bump it off in the night.Apple actually makes a proper resting charging pad for the Watch, but it s a bunch more money when it really should just come for free, given how frustrating it is.